The rising health crisis of congenital syphilis: What physicians can do

Congenital syphilis, a disease passed to babies during pregnancy, is increasing worldwide, with between 700,000 and 1.5 million reported cases annually over the past eight years. The disease can cause stillbirths, disability and death. To better understand this issue, a team of UC Davis pediatricians wrote a literature review, published in the journal Children, to illuminate this rising health threat and offer potential countermeasures.

Findings highlight importance of early monitoring and management of hypertension during and after pregnancy

Hispanic/Latina women with a history of hypertensive disorders of pregnancy (HDP)—conditions marked by high blood pressure during pregnancy—are more likely to have abnormalities in their heart structure and function decades later when compared with women without a history of HDP, according to a National Institutes of Health-supported study.

Zambia ready to become self-sufficient in medicine production – Pharmanova

ZAMBIA and Africa as a whole have for far too long relied on foreign pharmaceutical products and the 3rd International Conference on Public Health in in Africa (CPHIA) has served as an ideal avenue to explore ways of how the country can boost its pharmaceutical manufacturing capabilities, Mohammed Umar, the chief executive officer of Pharmanova Zambia has said.

This content is locked

This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.


Patients listed as alive in their electronic health records were actually deceased, according to data

About 20% of patients whose medical records showed them as being alive with a serious illness were in fact deceased according to California data, leading to hundreds of unnecessary interactions such as appointment reminders, prescription refills and other kinds of wasteful outreach that strain resources and health care workers’ time.

New study maps ketamine’s effects on brain

Ketamine—an anesthetic also known for its illicit use as a recreational drug—has undergone a thorough reputational rehabilitation in recent years as the medical establishment has begun to recognize its wide-ranging therapeutic effects. The drug is increasingly used for a range of medical purposes, including as a painkiller alternative to opioids, and as a therapy for treatment-resistant depression.